Protara Therapeutics (TARA) Share-based Compensation (2013 - 2026)

Protara Therapeutics (TARA) has 14 years of Share-based Compensation data on file, last reported at $11.6 million in Q1 2026.

• On a quarterly basis, Share-based Compensation rose 9520.66% year-over-year to $11.6 million in Q1 2026; TTM through Mar 2026 was $11.6 million, a 687.62% increase from a year earlier, with the FY2025 full-year figure at $5.9 million, up 61.34% from the prior year.
• Share-based Compensation for Q1 2026 stood at $11.6 million, up from $1.0 million in the prior quarter.
• Over the last five years, Share-based Compensation for TARA reached as high as $11.6 million in Q1 2026 and fell as low as $111000.0 in Q2 2024.
• Historically, Share-based Compensation has averaged $1.6 million across 5 years, with a median of $1.1 million in 2024.
• Across the five-year window, Share-based Compensation slumped 91.41% in 2024 and jumped 9520.66% in 2026, its largest moves.
• Year by year, Share-based Compensation stood at $1.4 million in 2022, then advanced by 1.54% to $1.5 million in 2023, then slumped by 70.8% to $424000.0 in 2024, then jumped by 145.99% to $1.0 million in 2025, then jumped by 1016.11% to $11.6 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $11.6 million in Q1 2026, $1.0 million in Q4 2025, and $851000.0 in Q3 2025.